1379649-46-3

Upstream product

• 1379649-43-0 3-(3,4-dimethylphenyl)-2-(3-fluorophenyl)propanenitrile 
• 1379649-42-9 (2E)-3-(3,4-dimethylphenyl)-2-(3-fluorophenyl)acrylonitrile 
• 5973-71-7 3,4-dimethylbenzaldehyde 
• 501-00-8 3-fluorophenylacetonitrile 
• 1379649-44-1 {4-[(1E)-4-(3,4-dimethylphenyl)-3-(3-fluorophenyl)but-1-en-1-yl]phenyl}methanol 
• 1379649-45-2 methyl 4-[(1E)-4-(3,4-dimethylphenyl)-3-(3-fluorophenyl)but-1-en-1-yl]benzoate 
• 1379649-41-8 3-(3,4-dimethylphenyl)-2-(3-fluorophenyl)propanal 
• 78022-19-2 dimethyl (4-carbomethoxybenzyl)phosphonate 

Downstream Products

• 1379928-80-9 3-({4-[(1E)-4-(3,4-dimethylphenyl)-3-(3-fluorophenyl)but-1-en-1-yl]benzyl}amino)propanoic acid 
• 1379928-82-1 [3-({4-[(1E)-4-(3,4-dimethylphenyl)-3-(3-fluorophenyl)but-1-en-1-yl]benzyl}amino)propyl]phosphonic acid 

Relevant academic research and scientific papers

NOVEL AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS

The present invention relates to novel azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.

ALKYNE AND ALKENE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE-1 RECEPTOR MODULATORS

The present invention relates to novel alkyne and alkene derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.